Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC)
Showing 26 - 50 of 1,408
Hiv Trial in Cape Town (Tenofovir alafenamide, Tenofovir Disoproxil Fumarate)
Recruiting
- Hiv
- Tenofovir alafenamide
- Tenofovir Disoproxil Fumarate
-
Cape Town, South AfricaGugulethu Midwife Obstetric Unit
Nov 1, 2022
HIV Trial in Worldwide (daily TDF/FTC, Placebo)
Completed
- HIV Infections
- daily TDF/FTC
- Placebo
-
San Francisco, California
- +10 more
Oct 29, 2021
HIV Trial in Worldwide (Oral FTC/TDF (Daily Emtricitabine/Tenofovir Disoproxil fumarate Tablet), Rectal Daily TFV RG 1% gel
Completed
- HIV
- Oral FTC/TDF (Daily Emtricitabine/Tenofovir Disoproxil fumarate Tablet)
- +2 more
-
San Francisco, California
- +7 more
Jun 22, 2021
HIV-1 Infection Trial in Worldwide (Etoposide (ET), Bleomycin and Vincristine (BV), Paclitaxel (PTX))
Completed
- HIV-1 Infection
- Etoposide (ET)
- +3 more
-
Rio de Janeiro, Brazil
- +10 more
Sep 24, 2021
HIV-1-infection Trial in Shanghai, Kunming, Hangzhou (B/F/TAF, TDF-based triple ART regimen switching to B/F/TAF)
Recruiting
- HIV-1-infection
- B/F/TAF
- TDF-based triple ART regimen switching to B/F/TAF
-
Shanghai, Shanghai, China
- +2 more
Dec 1, 2022
HIV Trial (Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg)
Completed
- HIV Infections
- Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg
- (no location specified)
May 11, 2022
Acceptability of Health Care, Adherence, Medication Trial in Durban, Pietermaritzburg, Harare (emtricitabine/tenofovir
Recruiting
- Acceptability of Health Care
- Adherence, Medication
- emtricitabine/tenofovir alafenamide
- Emtricitabine / Tenofovir Disoproxil Oral Tablet
-
Durban, KZN, South Africa
- +2 more
Jul 12, 2022
HIV-1 Infection Trial in United States (Emtricitabine/rilpivirine/tenofovir disoproxil fumarate)
Completed
- HIV-1 Infection
- Emtricitabine/rilpivirine/tenofovir disoproxil fumarate
-
Birmingham, Alabama
- +18 more
Jul 31, 2021
HIV Infection Trial (dolutegravir (DTG)/emtricitabine (FTC)/tenofovir alafenamide (TAF) regimen)
Not yet recruiting
- HIV Infection
- dolutegravir (DTG)/emtricitabine (FTC)/tenofovir alafenamide (TAF) regimen
- (no location specified)
Aug 8, 2023
Drug Interaction Trial in Bangkok (Emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (F/TDF) and emtricitabine 200
Recruiting
- Drug Interaction
- Emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (F/TDF) and emtricitabine 200 mg/tenofovir alafenamide 25 mg (F/TAF)
-
Bangkok, Pathumwan, ThailandInstitute of HIV Research and Innovation (IHRI)
Apr 21, 2022
HIV Preexposure Prophylaxis Trial in Worldwide (ISL, FTC/TDF, FTC/TAF)
Active, not recruiting
- HIV Preexposure Prophylaxis
- ISL
- +5 more
-
Birmingham, Alabama
- +24 more
Aug 15, 2022
HIV Trial in Johannesburg (Cabotegravir Injection [Apretude], Tenofovir disoproxil fumarate / emtricitabine (or lamivudine))
Not yet recruiting
- HIV Infections
- Cabotegravir Injection [Apretude]
- Tenofovir disoproxil fumarate / emtricitabine (or lamivudine)
-
Johannesburg, Gauteng, South AfricaEzintsha, a division of Wits Health Consortium
Nov 13, 2023
Hepatitis B, Chronic Trial in Toronto (Tenofovir disoproxil fumarate)
Active, not recruiting
- Hepatitis B, Chronic
- Tenofovir disoproxil fumarate
-
Toronto, Ontario, CanadaUniversity Health Network - Toronto General Hospital
Nov 1, 2022
Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (Dolutegravir (DTG), Lamivudine (3TC), Tenofovir disoproxil
Active, not recruiting
- Infection, Human Immunodeficiency Virus
- HIV Infections
- Dolutegravir (DTG)
- +2 more
-
Phoenix, Arizona
- +89 more
Jun 27, 2022
HIV-1-infection Trial in Edmonton (B/F/TAF, Atripla, B/F/TAF Placebo)
Terminated
- HIV-1-infection
- B/F/TAF
- +3 more
-
Edmonton, Alberta, CanadaUniversity of Alberta
Nov 21, 2022
Chronic Hepatitis B Trial in Hong Kong (Tenofovir alafenamide(TAF), Tenofovir disoproxil fumarate(TDF))
Recruiting
- Chronic Hepatitis B
- Tenofovir alafenamide(TAF)
- Tenofovir disoproxil fumarate(TDF)
-
Hong Kong, Hong KongHumanity and Health GI and Liver Centre
Dec 19, 2022
HIV Trial in Seoul (tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral
Unknown status
- HIV Infections
- tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
-
Seoul, Korea, Republic ofYonsei Severance Hospital
Oct 5, 2020
HIV Prevention Trial in Fremantle, Mount Lawley, Perth (Tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC))
Completed
- HIV Prevention
- Tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC)
-
Fremantle, Western Australia, Australia
- +3 more
Sep 3, 2020
Hiv Trial in France (Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO])
Not yet recruiting
- Hiv
- Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO]
-
Caen, France
- +3 more
Sep 6, 2023
Chronic Hepatitis B Trial in Auckland (TAF, TDF, Other approved antivirals)
HIV Trial in United States (Kaletra + Isentress, Atripla)
Primary Biliary Cholangitis Trial in Canada (Emtricitabine (FTC)/Tenofovir Disoproxil (TDF), Raltegravir, Placebo Oral Capsule
Recruiting
- Primary Biliary Cholangitis
- Emtricitabine (FTC)/Tenofovir Disoproxil (TDF)
- +2 more
-
Edmonton, Alberta, Canada
- +5 more
Mar 15, 2022
HIV, Weight Gain Trial in Helsinki (gastroscopy)
Not yet recruiting
- HIV Infections
- Weight Gain
- gastroscopy
-
Helsinki, Uusimaa, FinlandInfectious Disease Clinic, Helsinki University Hospital
Apr 6, 2022
HIV Trial in Worldwide (Darunavir (DRV) 800 milligram (MG) Oral Tablet, Ritonavir 100 MG Oral Tablet, N(t)RTIs)
Recruiting
- HIV Infections
- Darunavir (DRV) 800 milligram (MG) Oral Tablet
- +6 more
-
Chennai, India
- +6 more
Aug 30, 2021